Responses
Current Concepts in the Management of Gynecologic Tumors
Comparison of combination therapy with paclitaxel Taxol® and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study
Compose a Response to This Article
Other responses
No responses have been published for this article.